Summary
- Profile Type
- Business Offer
- POD Reference
- BODE20240912021
- Term of Validity
- 12 September 2024 - 12 September 2025
- Company's Country
- Germany
- Type of partnership
- Commercial agreement
- Targeted Countries
- All countries
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- The German SME with many years of experience and expertise in pharmaceutical logistics, offers a specialized logistics service for highly sensitive goods. This solution not only meets the high quality and safety requirements of clinics, R&D facilities, start-ups and other smaller institutions, but also offers flexibility and cost efficiency even with low transport volumes. To this end, the company is looking for (pilot) customers amongst these institutions throughout Europe.
- Full Description
-
For more than three decades, the logistic experts have been offering their state-of-the-art pharmaceutical logistics and future-oriented solutions for the transport and storage of highly sensitive goods.
As a member of the Transport Asset Protection Association (TAPA), they offer the highest security standards in both distribution and warehousing.
Compliance with current GMP and GDP guidelines is a fundamental part of their high-quality standards.
In summary they are the only logistics company in Europe which combines certifications according to GDP, TAPA TSR 1 and TAPA FSR A with the status of regulated agent under one umbrella at their headquarters.
Their wholesale authorisation in accordance with § 52a AMG is a further proof of their pharmaceutically compliant actions and thinking.
150 trailers specifically developed for the transportation requirements of pharmaceutical and temperature-controlled goods, operate throughout Europe at least twice a week.
The company offers European-wide time critical courier services within temperature range -196 °C to +20 °C, which provide the perfect logistics solution for clinical trials or laboratory samples.
Now they wish to extend their flexible and sustainable “Less Than Truckload” (LTL) network, which combines the highest quality and safety requirements (up to S2) with cost effectiveness to smaller research institutions, start-ups, universities, clinics, laboratories and centers for personalized medicine throughout Europe. - Advantages and Innovations
-
The company's “Less Than Truckload” (LTL) network is unique within Europe. In total 15-30 shipments from an average of 5-8 customers are transported at the same time in one specially segmented trailer, with multiple stops for loading and unloading.
The advantages that participation in the network can offer smaller companies, even if the individual transport volumes are small, are:
• Cost-effective use of an established, specialized transport network with 150 HGV trailers operating throughout Europe at least twice a week
• Guarantee of the highest quality and safety standards for transportation (product integrity, theft protection, etc.: GDP, TAPA TSR 1 and TAPA FSR A)
• Individually customizable, needs-based transport conditions (up to S2) through specially segmented trailers and multiple stops
• Transport of a medical facility load exclusively with other medical products, even in segmented trailers - Stage of Development
- Already on the market
- Sustainable Development Goals
- Goal 12: Responsible Consumption and Production
- Goal 3: Good Health and Well-being
- Goal 9: Industry, Innovation and Infrastructure
- IPR status
- No IPR applied
Partner Sought
- Expected Role of a Partner
-
They are actively looking for (pilot) customers who are interested in
• discussing their individual transportation needs with them
• implement (and eventually adapt) the specialized sustainable logistics solution from the pharmaceutical market for research and clinical applications
• becoming part of the unique “Less Than Truckload” (LTL) network as a customer
They are targeting clinics, R&D facilities, start-ups, etc. that need to transport sensitive, valuable and/or therapy-critical biomaterials. - Type and Size of Partner
- Big company
- Other
- University
- SME 11-49
- SME 50 - 249
- R&D Institution
- SME <=10
- Type of partnership
- Commercial agreement
Dissemination
- Technology keywords
- 01004003 - Applications for Transport and Logistics
- 06001015 - Pharmaceutical Products / Drugs
- 01004001 - Applications for Health
- 06001002 - Clinical Research, Trials
- 06001024 - Medical Biomaterials
- Market keywords
- 05005022 - Other clinical medicine
- 04006 - Cellular and Molecular Biology
- 09001002 - Trucking
- 09001007 - Other transportation
- 05007002 - Pharmaceuticals/fine chemicals
- Sector Groups Involved
- Health
- Mobility - Transport - Automotive
- Targeted countries
- All countries
